GPC4 truncating variant associated with Keipert syndrome and lacrimal punctal agenesis
American Journal of Medical Genetics Part A · 2024
DOI: 10.1002/ajmg.a.63799 ↗Kurz gefasst
Fallbericht in der Zeitschrift American Journal of Medical Genetics Part A, 2024. Verfasst von Yukiko Kuroda und 5 weiteren Autor:innen. Beteiligte Einrichtung: Division of Medical Genetics, Kanagawa Children's Medical Center, Yokohama, Japan. Hauptthemen laut MEDLINE: Glypicans, Lacrimal Apparatus, Abnormalities, Multiple. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 17 Literaturangaben. Gefördert von: The Japan Agency for Medical Research and Development (AMED), Ministry of Health, Labour and Welfare, Japan Society for the Promotion of Science KAKENHI.
Abstract (Originalsprache)
Lacrimal punctal agenesis is an extremely rare condition with an unclear genetic basis. Here, we report a 3‐year‐old male patient harboring a hemizygous variant in glypican 4 ( GPC4 ), which causes Keipert syndrome, who presented with complete lacrimal punctal agenesis, distinctive craniofacial features, mild developmental delay, mild intellectual disability, and autism. The craniofacial features included a prominent forehead, epicanthus, depressed and broad nasal bridge, hypoplastic columella, midface hypoplasia, tented upper lip, and low‐set ears. Proband exome sequencing identified a hemizygous variant in GPC4 : NM_001448.3:c.1051C > T (p.Arg351*). The GPC4 variant was inherited from his heterozygous mother; X‐inactivation followed a skewed pattern in his mother. This patient demonstrated clinical features consistent with Keipert syndrome including craniofacial features, brachydactyly, broad distal phalanx, broad first toe, and mild developmental delay; however, agenesis of the lacrimal puncta has not been reported previously in Keipert syndrome. Our findings suggest that GPC4 , which encodes a heparan‐sulfate proteoglycan, may play an important role in lacrimal morphogenesis. Our observations also suggest that Keipert syndrome should be considered in patients with lacrimal punctal agenesis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Medical Genetics, Kanagawa Children's Medical Center, Yokohama, Japan.
- Clinical Research Institute, Kanagawa Children's Medical Center, Yokohama, Japan.
- Division of Ophthalmology, Kanagawa Children's Medical Center, Yokohama, Japan.
ORCID-Profile: Yukiko Kuroda, Kenji Kurosawa
Förderung
- The Japan Agency for Medical Research and Development (AMED)
- Ministry of Health, Labour and Welfare
- Japan Society for the Promotion of Science KAKENHI
- Japan Agency for Medical Research and Development
- Japan Society for the Promotion of Science
Zitieren
APA
Kuroda, Y., Uehara, T., Enomoto, Y., Naruto, T., Matsumura, N., & Kurosawa, K. (2024). GPC4 truncating variant associated with Keipert syndrome and lacrimal punctal agenesis. American Journal of Medical Genetics Part A. https://doi.org/10.1002/ajmg.a.63799
Vancouver
Kuroda Y, Uehara T, Enomoto Y, Naruto T, Matsumura N, Kurosawa K. GPC4 truncating variant associated with Keipert syndrome and lacrimal punctal agenesis. American Journal of Medical Genetics Part A. 2024. doi:10.1002/ajmg.a.63799
BibTeX
@article{Kuroda2024,
author = {Kuroda, Yukiko and Uehara, Takeshi and Enomoto, Yumi and Naruto, Takuya and Matsumura, Nozomi and Kurosawa, Kenji},
title = {GPC4 truncating variant associated with Keipert syndrome and lacrimal punctal agenesis},
journal = {American Journal of Medical Genetics Part A},
year = {2024},
doi = {10.1002/ajmg.a.63799}
}
EUVIMED